PJPvsTMEDETF Comparison
VS
Invesco Dynamic Pharmaceuticals ETF (PJP) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. PJP's top 1 sector exposures are Healthcare. In contrast, TMED's top sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. PJP is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.44% for TMED. PJP is up 19.1% year-to-date (YTD) with +$166M in YTD flows. TMED performs worse with 15.44% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of PJP and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PJP vs TMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/15/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PJP TMED | -1.81%-2.57% | +9.81%+7.69% | +19.10%+15.44% | +37.54%+34.35% | +68.17%n/a | +64.54%n/a |
| Flows | PJP TMED | +$36M+$4M | +$158M+$9M | +$166M+$13M | +$180M+$15M | +$114M- | -$33M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PJP TMED | +18.21%+18.16% | +17.03%+18.40% | +16.36%n/a | +16.48%n/a |
| Max drawdown | PJP TMED | -5.90%-7.92% | -9.42%-11.09% | -16.11%n/a | -17.41%n/a |
| Max drawdown duration | PJP TMED | 27d26d | 108d125d | 275dn/a | 788dn/a |
Trading data
PJP | TMED | |
Last sale 9/15/2026 at 1:30 PM | $123.76 | $33.92 |
| Previous close 09/15/2026 | $124.96 | $34.28 |
| Consolidated volume 09/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
TMED
is actively managed and doesn’t replicate an indexPJP | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/15/2026 at 1:30 PM
Live
Closed
PJP | TMED | |
|---|---|---|
| Last price | $123.76 | $33.92 |
| 1D performance | -0.96% | -1.06% |
| AuM | $542.28 M | $32.55 M |
| E/R | 0.58% | 0.44% |
Characteristics
PJP | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | T. Rowe Price |
| Benchmark | Dynamic Pharmaceutical Intellidex Index | - |
| N° of holdings | 28 | 97 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | June 11, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
PJP
USA
94.69%
Other
5.31%
TMED
USA
93.59%
Other
6.41%
Sectors
PJP
Healthcare
100%
Other
-0%
TMED
Healthcare
98.58%
Other
1.42%
Diversification
PJP
Total weight of top 15 holdings out of 15
65.5%
TMED
Total weight of top 15 holdings out of 15
61.11%
Top 15 holdings
Data as of July 31, 2026
PJP
Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4.00%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.10%
Viatris, Inc.
2.85%
TMED
Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.30%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.60%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.20%
McKesson Corp.
1.72%
Frequently asked questions about PJP and TMED
How have the PJP and TMED ETFs performed in 2026?
As of September 15, 2026, PJP is up 19.1% year-to-date (YTD), while TMED has returned 15.44%. That puts PJP better performer ahead so far this year.
Which ETF is attracting more investor money: PJP or TMED?
Year-to-date, the PJP ETF saw +$166M in flows, compared to +$13M for TMED.
Which ETF is more volatile: PJP or TMED?
Over the past year, PJP had a volatility of 17.03%, while TMED experienced 18.4%.
Which ETF is bigger: PJP or TMED?
As of September 15, 2026, PJP holds $542.28 M in assets under management (AUM), while TMED manages $32.55 M.
What sectors do the PJP and TMED ETFs invest in?
PJP leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.
What are the top holdings of the PJP ETF and TMED ETF?
PJP top holdings include Abbott Laboratories, AbbVie, Inc. and Amgen, Inc.. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..
Which ETF is more diversified: PJP or TMED?
PJP holds 28 securities with 65.5% of its assets in the top 15. TMED has 97 securities and a top 15 weight of 61.11%.
Advertisement
Advertisement
